LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 265 filers reported holding LIGAND PHARMACEUTICALS INC in Q3 2016. The put-call ratio across all filers is 1.06 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $356,000 | -58.1% | 2,620 | -15.3% | 0.23% | -49.7% |
| Q3 2018 | $850,000 | -27.4% | 3,095 | -50.8% | 0.46% | +40.5% |
| Q2 2018 | $1,171,000 | +125.6% | 6,290 | +100.0% | 0.33% | +12.6% |
| Q1 2018 | $519,000 | -39.8% | 3,145 | -50.0% | 0.29% | +25.1% |
| Q4 2017 | $862,000 | +5.5% | 6,290 | -0.8% | 0.24% | -2.1% |
| Q3 2017 | $817,000 | +112.2% | 6,340 | +100.0% | 0.24% | +4.3% |
| Q2 2017 | $385,000 | +14.6% | 3,170 | 0.0% | 0.23% | +11.7% |
| Q1 2017 | $336,000 | +4.3% | 3,170 | 0.0% | 0.21% | -4.2% |
| Q4 2016 | $322,000 | +1.3% | 3,170 | +1.6% | 0.22% | +0.5% |
| Q3 2016 | $318,000 | -8.6% | 3,120 | +6.8% | 0.21% | -9.3% |
| Q2 2016 | $348,000 | +12.6% | 2,920 | +1.0% | 0.24% | +9.3% |
| Q1 2016 | $309,000 | – | 2,890 | – | 0.22% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 2,626,160 | $138,136,000 | 24.17% |
| KNOTT DAVID M | 1,292,566 | $67,988,972,000 | 13.87% |
| GROW Partners, LLC | 200,000 | $10,520,000 | 6.41% |
| Opaleye Management Inc. | 90,000 | $4,860,000,000 | 3.82% |
| OBERWEIS ASSET MANAGEMENT INC/ | 213,317 | $11,220,000 | 2.72% |
| First Light Asset Management, LLC | 60,242 | $3,169,000 | 2.69% |
| Timpani Capital Management LLC | 98,956 | $5,205,000 | 2.59% |
| Iguana Healthcare Management, LLC | 75,000 | $3,945,000 | 2.25% |
| Eventide Asset Management | 134,400 | $7,069,000 | 2.18% |
| ASHFORD CAPITAL MANAGEMENT INC | 215,223 | $11,321,000 | 2.16% |